Business Context and Reporting Period
Company: The Pennant Group, Inc. (PNTG)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2025
Business Overview: Pennant is a holding company providing post-acute care services through independent operating subsidiaries. Its portfolio includes home health, hospice, home care, and senior living services across 16 states. As of December 31, 2025, the company operated 172 home health and hospice agencies and 63 senior living communities with 4,428 units. The company utilizes a decentralized "cluster" operating model to empower local leaders.
Key Financial Metrics
| Metric (in thousands) | 2025 | 2024 | Change |
|---|---|---|---|
| Total Revenue | $947,705 | $695,240 | +36.3% |
| Net Income (GAAP) | $33,764 | $24,339 | +38.7% |
| Net Income Attributable to Pennant | $29,578 | $22,559 | +31.1% |
| Diluted EPS | $0.84 | $0.70 | +20.0% |
| Operating Income | $51,886 | $38,116 | +36.1% |
| Consolidated Adjusted EBITDAR | $120,901 | $81,925 | +47.6% |
| Operating Cash Flow | $48,294 | $39,298 | +22.9% |
| Total Debt (Principal) | $175,000 | $0 | N/A |
| Cash and Equivalents | $17,024 | $24,246 | -29.8% |
Note: Consolidated Adjusted EBITDAR for 2024 is calculated as Adjusted EBITDA ($53,286) + Rent ($42,496) + Rent adjustments ($6,143) based on reconciliation tables.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased by $252.5 million (36.3%), driven by $185.0 million from acquisitions and $67.5 million from organic growth.
- Home Health & Hospice: Revenue rose 41.0% to $732.7 million, fueled by a 44.1% increase in home health admissions and a 28.6% increase in hospice daily census.
- Senior Living: Revenue rose 22.3% to $215.0 million, driven by an 8.0% increase in revenue per occupied unit and a 90 basis point increase in occupancy (79.7%).
- Acquisitions: The company significantly expanded its footprint in 2025, acquiring 30 home health agencies, 9 hospice agencies, 4 home care agencies, and 6 senior living communities. A major transaction in Q4 involved the acquisition of 21 home health, 5 hospice, and 4 home care agencies from UnitedHealth/Amedisys in Alabama, Georgia, and Tennessee.
- Cost Structure: Cost of services increased 37.6% to $768.5 million, primarily due to volume growth and wage inflation. Cost of services as a percentage of revenue increased 80 basis points to 81.1%.
- Capital Structure: The company moved from a debt-free position in 2024 to carrying $175 million in debt in 2025. This includes a $100 million incremental term loan and $75 million drawn on a $250 million revolving credit facility. The company also completed a secondary equity offering in late 2024 raising $118.1 million.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: Management expects continued growth driven by organic census improvements and a disciplined acquisition strategy in fragmented markets. The company anticipates that recently acquired operations may initially show lower margins due to integration costs and lower occupancy/census.
- Regulatory Risks:
- Medicare/Medicaid: 61.5% of revenue is derived from government payors. The company faces risks from reimbursement rate changes, including a -1.3% net payment update for home health in 2026 and potential impacts from the "One Big Beautiful Bill Act" (OBBBA) on Medicaid funding.
- Compliance: The company is subject to frequent audits (RAC, ZPIC, UPIC). Adverse findings could lead to recoupments, fines, or exclusion from programs.
- Operational Risks:
- Labor: 68.3% of expenses are payroll-related. Shortages of skilled staff and wage inflation remain significant headwinds.
- Leases: The company leases 57 of its 63 senior living communities under triple-net leases. Lease defaults could trigger cross-defaults on debt.
- Cybersecurity: The company notes increased frequency and severity of cyber threats in 2025, though no material breaches were reported in the past five years.
- Unusual Items:
- Acquisition Costs: $6.6 million in acquisition-related costs were incurred in 2025, primarily related to the UnitedHealth/Amedisys transaction.
- Share-Based Compensation: Increased to $9.0 million in 2025 from $8.2 million in 2024.
Investor Verification Checklist
- Acquisition Integration: Verify the timeline and financial performance of the 43 new home health/hospice agencies and 6 senior living communities acquired in 2025, specifically the UnitedHealth/Amedisys portfolio.
- Debt Covenants: Review the specific leverage ratios and interest coverage requirements in the Amended Credit Agreement to ensure compliance given the new $175 million debt load.
- Reimbursement Sensitivity: Assess the impact of the 2026 Home Health Prospective Payment System (HH PPS) final rule (-1.3% update) on future margins.
- Self-Insurance Reserves: Review the actuarial assumptions for the $17.6 million in self-insurance reserves (general liability and workers' comp), identified as a critical audit matter.
- Lease Obligations: Analyze the $417.5 million in future operating lease payments and the risk of cross-defaults associated with master lease agreements.